Pathological role of RAGE underlying progression of various diseases: its potential as biomarker and therapeutic...

Area of Science:

• Biochemistry and Molecular Biology
• Immunology
• Pathology

Background:

• The receptor for advanced glycation end products (RAGE) is a pattern recognition receptor involved in various cellular functions.
• RAGE-ligand interactions contribute to chronic inflammation and oxidative stress, implicated in numerous diseases including metabolic syndrome, neurodegeneration, cardiovascular and pulmonary disorders, cancer, and infections.
• Despite extensive research, RAGE has not yet been integrated into mainstream clinical management.

Purpose of the Study:

• To review the pathological mechanisms driven by RAGE.
• To evaluate the potential of RAGE as a diagnostic biomarker.
• To assess RAGE as a therapeutic target for various diseases.

Main Methods:

• Literature review of studies involving RAGE.
• Analysis of RAGE's role in different pathological conditions.
• Examination of RAGE targeting strategies (small molecule inhibitors, peptides, natural compounds).

Main Results:

• RAGE is a key mediator in chronic inflammation and oxidative damage.
• RAGE's involvement is demonstrated across a wide spectrum of diseases.
• Various therapeutic strategies targeting RAGE have been explored in preclinical and clinical settings.

Conclusions:

• RAGE plays a significant role in the pathogenesis of multiple chronic diseases.
• RAGE holds promise as a potential biomarker for disease diagnosis and prognosis.
• Targeting RAGE presents a viable therapeutic strategy for managing a range of debilitating conditions.